Cervical cancers: diagnostic and therapeutic aspects at the regional hospital of Thies
Main Article Content
Abstract
Objective: The objective of our study was to determine the epidemiological profile of patients with cervical cancer, the diagnostic stage and to describe the therapeutic and prognostic features.
Patients and method: We conducted a descriptive retrospective study from January 1, 2015 to December 31, 2018 on 64 patients with cervical cancer. We used epidemiological, clinical, paraclinical and therapeutic data from patients treated in the maternity ward of the Regional Hospital of Thiès for cervical cancer. Results: During the study period, we retained 64 files of patients with cervical cancer. The mean age of the patients was 56.6 years with extremes ranging from 25 years to 90 years. Most of the patients were housewives (87.5%), multiparous in 84.4% of cases.The main reason for consultation was isolated metrorrhagia (64%). Fifty-three patients, ie 82.8% of cases, consulted at a stage beyond FIGO Ib1. Sixty-one patients (95.3%) had squamous cell carcinoma. Radiotherapy was indicated in 38 women, ie 59.4% and 7 or 18.4% had benefited from it. Colpohysterectomy with first lymhadenectomy (CHL) was performed in 11 patients, ie 17.2%. Pelvic recurrence was noted in 5 patients, ie 7.8%. Twenty-three patients (35.9%) had overall survival at 12 months. Twenty-seven had died or 42.2% of cases and 14 were lost to follow-up or 21.9% of cases. Conclusion: Cervical cancer is a real public health problem, especially in our structure where it is a major cause of death from cancer. This mortality is linked to late diagnosis and the inaccessibility of certain treatments, particularly radiotherapy. The fight against cervical cancer necessarily involves the implementation of screening programs and early and appropriate management of cervical cancer in our country. Visual inspection techniques (IVA and IVL) constitute a simple and reliable alternative and should be further popularized in our countries with limited resources for early detection of precancerous lesions.